US$ 25.04
glp-1 anesthesia news A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general Are Serious Anesthesia Risks of
Description
[PMID: 37688299]

In both studies, participants read descriptions about a fictional 38-year-old individual who had experienced obesity since puberty

In addition to impaired EEC signaling and gut peptide release, GF models have impaired ENS activation compared with conventionalized and specific-pathogen-free models 245,246

Prescription GLP-1 agonists commonly cause nausea, reduced appetite, and GI changeseffects that typically diminish over time
